$SLS Wonder why proven longs are looking at the ER as suspicious. For once it's a no surprise ER. They raised 25M in a shitty bio market. Next target is 5.40. Anyone thinks those who bought at 5.40 didn't do a good DD and are idiots? And they were not shorts covering since there was never more than about 1M shares short and the offering was 4M shares. Was very frustating over last 12 months but was all POS XBI and covid. The future is looking great imo. Let's be positive until EOQ data. Then we'll know if we're screwed or winners. GLTA!